INHBE and esophageal adenocarcinoma: When Activin signaling was inhibited with siRNA targeting the Activin A gene, INHBA, or with the Activin antagonist, Follistatin, esophageal adenocarcinoma cell lines demonstrated suppressed proliferation [17].